Structure Therapeutics (GPCR) Shareholder's Equity (2022 - 2026)
Structure Therapeutics (GPCR) Shareholder's Equity (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
860,679.92 Bn |
860,679.89 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,284.00 Bn |
55,284.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
16,206.94 Bn |
16,206.93 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,318.00 Bn |
3,317.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,543.84 Bn |
1,543.84 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,449.11 Bn |
1,449.09 Bn |
- |
- |
| 7 |
Psyence Biomedical |
216.99 Bn |
216.98 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
115.22 Bn |
107.97 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
90.58 Bn |
90.58 Bn |
- |
502.95 Mn |
| 10 |
Structure Therapeutics |
9.31 Bn |
9.31 Bn |
- |
1.45 Bn |
| Date | Value |
|---|
| Mar 31, 2026 |
1.45 Bn |
| Dec 31, 2025 |
1.52 Bn |
| Sep 30, 2025 |
770.02 Mn |
| Jun 30, 2025 |
772.08 Mn |
| Mar 31, 2025 |
824.64 Mn |
| Dec 31, 2024 |
864.84 Mn |
| Sep 30, 2024 |
896.80 Mn |
| Jun 30, 2024 |
921.03 Mn |
| Mar 31, 2024 |
429.82 Mn |
| Dec 31, 2023 |
452.97 Mn |
| Sep 30, 2023 |
192.96 Mn |
| Jun 30, 2023 |
214.42 Mn |
| Mar 31, 2023 |
236.35 Mn |
| Dec 31, 2022 |
-115.14 Mn |
| Sep 30, 2022 |
-103.91 Mn |
| Jun 30, 2022 |
-92.10 Mn |
| Mar 31, 2022 |
-77.23 Mn |
